Skip to main content

Table 1 Characteristics of Unmatched and Propensity Matched Patients

From: Does full sternotomy have more significant impact than the cardiopulmonary bypass time in patients of mitral valve surgery?

Characteristics

Unmatched Patients(n = 1120)

Matched Patients(n = 165)

Sternotomy(n = 837)

MIMVS(n = 283)

p Value

Sternotomy(n = 165)

MIMVS(n = 165)

p Value

Age (years)

57.5 ± 8.3

46.7 ± 7.2

0.000

52.6 ± 7.0

51.5 ± 6.8

0.1486

Sex (female)

485(57.9%)

108(38.2%)

0.000

56(33.9%)

58(35.2%)

0.817

Body mass index

25.2 ± 2.2

24.5 ± 1.3

0.000

25.6 ± 2.0

25.5 ± 2.0

0.6500

Rheumatic valvular disease (n)

468(55.9%)

162(57.2%)

0.384

94(57.0%)

96(58.2%)

0.487

Hypertension

302(36.1%)

60(21.2%)

0.000

36(21.8%)

35(21.2%)

0.893

Diabetes mellitus

143(17.1%)

56(19.8%)

0.304

30(18.1%)

31(18.8%)

0.887

Preoperative creatinine (mg/dL)

0.72 ± 0.19

0.77 ± 0.10

0.000

0.74 ± 0.13

0.75 ± 0.12

0.4683

LVEF, %

56.7 ± 6.9

61.6 ± 4.7

0.000

59.2 ± 4.2

59.5 ± 4.0

0.5069

Current congestive heart failure

259(30.9%)

51(18.0%)

0.000

38(23.0%)

36(21.8%)

0.792

History of AF

378(45.2%)

85(30.0%)

0.000

60(36.4%)

58(35.2%)

0.818

COPD

134(16.0%)

26(9.2%)

0.005

20(12.1%)

18(10.9%)

0.730

Cerebrovascular disease

76(9.1%)

14(4.9%)

0.027

11(6.7%)

10(6.1%)

0.822

preoperative NYHA functional class

2.6 ± 0.6

2.1 ± 0.5

0.0000

2.3 ± 0.5

2.3 ± 0.4

1.0000

NYHA III-IV functional class, n (%)

242(28.9%)

43(15.2%)

0.000

34(20.6%)

32(19.4%)

0.783

Pulmomary Hypertension (≥60 mmHg)

252(30.1%)

78(27.6%)

0.417

47(28.5%)

46(27.9%)

0.903

EuroSCORE I

6.5 ± 1.0

4.8 ± 0.8

0.000

5.9 ± 0.9

5.8 ± 0.8

0.287

  1. AF = atrial fibrillation; COPD = chronic obstructive pulmonary disease; NYHA = New York Heart Association; EuroSCORE I = European System for Cardiac Operative Risk Evaluation, version I